A general strategy towards personalized nanovaccines based on fluoropolymers for post-surgical cancer immunotherapy.
Xu J, Lv J, Zhuang Q, Yang Z, Cao Z, Xu L, Pei P, Wang C, Wu H, Dong Z, Chao Y, Wang C, Yang K, Peng R, Cheng Y, Liu Z.
Xu J, et al. Among authors: yang k, yang z.
Nat Nanotechnol. 2020 Dec;15(12):1043-1052. doi: 10.1038/s41565-020-00781-4. Epub 2020 Nov 2.
Nat Nanotechnol. 2020.
PMID: 33139933